FDA OKs First-Line Avelumab Maintenance in Bladder Cancer

(MedPage Today) -- The FDA expanded the approval of avelumab (Bavencio) on Tuesday, to include first-line maintenance in locally advanced or metastatic bladder cancer patients, drugmakers EMD Serono and Pfizer announced.
Approval of the PD-L1...